Deerfield Management Company, L.P. (Series C) - Significant Ownership

Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Deerfield Management Company, L.P. (Series C).

Significant Ownership of Deerfield Management Company, L.P. (Series C)

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
LRMR Larimar Therapeutics, Inc. Common Stock, par value $0.0001 per share 35.81% $82.5M 30.7M Deerfield Management Company, L.P. Jul 31, 2025
PHGE BiomX Inc. Common Stock, par value $0.0001 per share 9.99% $11.4M 15.6M Deerfield Management Company, L.P. Feb 27, 2025
SPRY ARS Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 7.75% $101M -$13.6M 7.61M -11.9% Deerfield Management Company, L.P. Jul 30, 2025

Schedules 13D/G Reported by Deerfield Management Company, L.P. (Series C):

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.